Devices › Nasopharyngoscope (flexible or rigid)
Device brand name · Rhino-laryngofiberscope
Rhino-Laryngofiberscope: medical device reports filed with FDA
331 reports name it, 2019–2026. Manufacturer given most often on reports: Shirakawa Olympus. Product code EOB.
- 331
- device reports naming the brand
- 0% of all MAUDE reports · about 46 a year
- 287
- reports, 12 months to August 2026
- 6 in the 12 months before
- 99.1%
- classified as malfunction
- 98.6% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
331 medical device reports received by FDA name the brand "Rhino-Laryngofiberscope" (rhino-laryngofiberscope); the manufacturer given most often on reports is Shirakawa Olympus; received from April 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
287 reports arrived in the 12 months to August 2026, up 4683% from 6 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.1%) and injury (0.9%); across all nasopharyngoscope (flexible or rigid) reports (product code EOB) death is recorded in 0% and malfunction in 98.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are detachment of device or device component (23.6%), failure to clean adequately (20.2%) and peeled/delaminated (9.4%). FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 8,127 reports carrying product code EOB. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Detachment of device or device componentpart of the device came off | 78 | 23.6% | 9% |
| Failure to clean adequately | 67 | 20.2% | 6% |
| Peeled/delaminated | 31 | 9.4% | 3.2% |
| Device reprocessing problem | 28 | 8.5% | 3.6% |
| Corrodedthe device corroded | 24 | 7.3% | 2.5% |
| Loss of or failure to bond | 23 | 6.9% | 1.7% |
| Material fragmentation | 21 | 6.3% | 2.3% |
| Breakthe device broke | 15 | 4.5% | 23.8% |
| Contamination | 11 | 3.3% | 1.1% |
| Residue after decontamination | 11 | 3.3% | 1% |
| Degraded | 9 | 2.7% | 1.2% |
| Material separation | 6 | 1.8% | 1.2% |
| Material split, cut or torn | 6 | 1.8% | 1.2% |
| Crackthe device cracked | 5 | 1.5% | 1.5% |
| Material discolored | 4 | 1.2% | 0.3% |
| Loose or intermittent connection | 3 | 0.9% | 0.1% |
| Poor quality image | 3 | 0.9% | 1.4% |
| Contamination /decontamination problem | 2 | 0.6% | 0.4% |
| Environmental particulates | 2 | 0.6% | 0.1% |
| Fluid/blood leak | 2 | 0.6% | 16.6% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
In context
| Measure | Rhino-Laryngofiberscope | Product code EOB | All MAUDE reports |
|---|---|---|---|
| Reports | 331 | 8,127 | 26,136,888 |
| Share of that pool | — | 4.1% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 0.9% | 1.3% | 36.2% |
| Classified as malfunction | 99.1% | 98.6% | 62.3% |
| Filed by the manufacturer | 100% | 99.4% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code EOB
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Pentax | 47,288 | 2,443 | 0.1% |
| Rhino-Laryngo Videoscope | 1,925 | 1,452 | 0% |
| Visera Rhino-Laryngo Videoscope | 283 | 194 | 0% |
| Rhino-Laryngo Fiberscope | 267 | 145 | 0% |
| PENTAX Medical | 1,349 | 807 | 0.3% |
| Videoarthroscope Hd 4mm X 30 Deg | 179 | 0 | 0% |
| 4k C-Mnt Scp 4 0 30 167 Mitek | 541 | 205 | 0% |
| Endoeye Flex Deflectable Videoscope | 8,062 | 2,245 | 0% |
| Bronchovideoscope | 1,924 | 938 | 0.1% |
| Single Use Suction Valve Sterile | 282 | 0 | 0% |
| Disposable Biopsy Forceps | 201 | 8 | 0% |
| Hd Epscp 4 0 30 167 Mitek | 575 | 27 | 0% |
| SINGLE USE BIOPSY VALVE (Sterile) | 293 | 130 | 0% |
| VISERA Pro VIDEO SYSTEM CENTER | 637 | 96 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Rhino-Laryngofiberscope reports
How many FDA reports name Rhino-Laryngofiberscope?
331 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 287 in the latest 12 months.
What kinds of events are reported?
malfunction (99.1%) and injury (0.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
detachment of device or device component (23.6%), failure to clean adequately (20.2%), peeled/delaminated (9.4%), device reprocessing problem (8.5%) and corroded (7.3%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Rhino-Laryngofiberscope was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.